Answers are grounded in this paper and cite their sources.
The levels of fecal SCFAs in the IgAN patients were reduced, and correlated with clinical parameters and gut microbiota, which may be involved in the pathogenesis of IgAN, and this finding may provide a new therapeutic approach.
No takes yet. Share an insight, caveat, or question.
Chai et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: